Search results for "Osteoprotegerin"

showing 10 items of 44 documents

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature oste…

2015

// Maria Rita Pitari 1 , Marco Rossi 1 , Nicola Amodio 1 , Cirino Botta 1 , Eugenio Morelli 1 , Cinzia Federico 1 , Annamaria Gulla 1 , Daniele Caracciolo 1 , Maria Teresa Di Martino 1 , Mariamena Arbitrio 2 , Antonio Giordano 3, 4 , Pierosandro Tagliaferri 1 , Pierfrancesco Tassone 1, 4 1 Department of Experimental and Clinical Medicine and T. Campanella Cancer Center, Magna Graecia University, S. Venuta University Campus, Catanzaro, Italy 2 ISN-CNR, Roccelletta di Borgia, Catanzaro, Italy 3 Department of Human Pathology and Oncology, University of Siena, Siena, Italy 4 Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology,…

Bone diseaseMessengerOsteoclastsTumor Microenvironment3' Untranslated RegionsMultiple myelomaTumorbiologyMesenchymal Stromal CellsRANKLProtein Inhibitors of Activated STATUp-Regulationmedicine.anatomical_structureOncologyRANKLmiRNAsmiR-21MiRNAMultiple MyelomaMiR-21; MiRNAs; Multiple myeloma bone disease; OPG; RANKL; 3' Untranslated Regions; Bone Marrow Cells; Bone Resorption; Cell Adhesion; Cell Line Tumor; Coculture Techniques; HEK293 Cells; Humans; Interleukin-6; Lentivirus; Mesenchymal Stromal Cells; MicroRNAs; Molecular Chaperones; Multiple Myeloma; Osteoclasts; Osteoprotegerin; Protein Inhibitors of Activated STAT; RANK Ligand; RNA Messenger; STAT3 Transcription Factor; Stromal Cells; Tumor Microenvironment; Up-Regulation; OncologyResearch Papermusculoskeletal diseasesSTAT3 Transcription FactorStromal cellBone Marrow CellsBone resorptionCell LineOsteoprotegerinCell Line TumormedicineCell AdhesionHumansRNA MessengerBone Resorptionbusiness.industryInterleukin-6LentivirusRANK LigandOsteoprotegerinMesenchymal Stem Cellsmedicine.diseaseMolecular medicineCoculture TechniquesMicroRNAsmultiple myeloma bone diseaseHEK293 CellsImmunologyCancer researchbiology.proteinRNAOPGBone marrowStromal CellsbusinessMolecular ChaperonesOncotarget
researchProduct

Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review

2015

Introduction: Orthodontic anchorage is one of the most challenging aspects of Orthodontics. Preventing undesired movement of teeth could result in safer and less complicated orthodontic treatment. Recently, several reviews have been published about the effects of different molecules on bone physiology and the clinical side effects in Orthodontics. However, the effects of local application of these substances on the rate of orthodontic tooth movement have not been assessed.Objectives: The aim of this research was to analyze the scientific evidence published in the literature about the effects of different molecules on orthodontic anchorage.Methods: The literature was systematically reviewed …

Bone remodeling periodBisfosfonatosTooth Movement TechniquesMovimentação dentáriaPharmacological managementAnti-Inflammatory AgentsOsteoclastsPamidronateDentistryZoledronic AcidAntioxidantsLactonesMiceStilbenesOrthodontic Anchorage ProceduresMedicineAgentes anti-inflamatóriosSulfonesAnti-inflammatory agentsOrthodonticsDiphosphonatesOsteoprotegerinaImidazolesOrthodontic anchorage proceduresArticlesBisphosphonatesProcedimentos de ancoragem ortodônticaTooth movementInclusion and exclusion criteriaBone RemodelingTooth MobilityOral SurgeryDiclofenacMEDLINEOrthodonticsKappa indexInterferon-gammaAnimalsHumansbusiness.industryOsteoprotegerinBone physiologyIsoxazolesOrthodontic Anchorage ProceduresAcetylcysteineRatslcsh:RK1-715CelecoxibResveratrolTooth movementlcsh:DentistryClodronic Acidbusiness
researchProduct

STUDIO DELLE INTERAZIONI E DELLE INFLUENZE DI OSTEOPROTEGERINA ED OSTEOPONTINA SULLE ALTERAZIONI VASCOLARI NELL’IPERTENSIONE ARTERIOSA ESSENZIALE

Ipertensione arteriosa essenzialeOsteoprotegerinaOsteopontina
researchProduct

Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid.

2020

Aim Alveolar resorption is one of the most important events in periodontitis. Osteoclast activity is regulated by the ratio between receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG). The aim of this study was to evaluate changes in the RANKL/OPG ratio in crevicular fluid after periodontal treatment. Material and methods A total of 15 patients with periodontitis were included in the study group. Samples were collected from an area with active periodontitis and a healthy area. The RANKL and OPG levels were measured before and after periodontal scaling and root planing (SRP) treatment. The study group was compared to the control group, which included 10 patients without peri…

MaleTeethAlveolar Bone LossOsteoclastsPathology and Laboratory MedicineAntiplatelet TherapyVascular Medicine0302 clinical medicineScaling and root planingOral DiseasesAnimal CellsMedicine and Health SciencesProspective StudiesProspective cohort studyConnective Tissue CellsMultidisciplinarybiologyPharmaceuticsQRGingival Crevicular FluidMiddle AgedHealthy VolunteersTreatment Outcomemedicine.anatomical_structureConnective TissueRANKL030220 oncology & carcinogenesisMedicineFemaleAnatomyCellular TypesPeriodontal IndexResearch Articlemusculoskeletal diseasesmedicine.medical_specialtyScienceOral MedicineHemorrhage03 medical and health sciencesSigns and SymptomsDrug TherapyOsteoprotegerinDiagnostic MedicineOsteoclastInternal medicinemedicineHumansPeriodontitisBonePeriodontal DiseasesAgedPeriodontitisbusiness.industryRANK LigandOsteoprotegerinCase-control studyBiology and Life SciencesRANK LigandCell Biology030206 dentistrymedicine.diseaseBiological TissueEndocrinologyJawCase-Control StudiesChronic Periodontitisbiology.proteinDental ScalingbusinessDigestive SystemHeadPLoS ONE
researchProduct

Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation

2009

Basic and clinical studies have suggested that inflammation predisposes to atrial fibrillation (AF). We assessed the association of 12 circulating inflammatory biomarkers (i.e., C-reactive protein, fibrinogen, interleukin-6, intercellular adhesion molecule-1, lipoprotein-associated phospholipase A2 [mass and activity], monocyte chemoattractant protein-1, myeloperoxidase, CD40 ligand, osteoprotegerin, P-selectin, and tumor necrosis factor receptor II) with incident AF in 2863 Framingham Offspring Study participants (mean age 60.7 years, SD = 9.4, 55% women). During follow-up (median 6 years), 148 participants (43% women) developed incident AF. In the multivariable proportional hazards models…

Malemedicine.medical_specialtyHeart diseaseArticleOsteoprotegerinRisk FactorsInternal medicineGermanyAtrial FibrillationConfidence IntervalsOdds RatioMedicineHumansMyocardial infarctionProspective StudiesInflammationFramingham Risk Scorebusiness.industryProportional hazards modelIncidenceHazard ratioOsteoprotegerinAtrial fibrillationMiddle Agedmedicine.diseaseSurvival AnalysisConfidence intervalC-Reactive ProteinMultivariate AnalysisCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkers
researchProduct

Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteobla…

2011

Osteoarthritis (OA) is a chronic degenerative joint disease showing altered bone metabolism. Osteoblasts contribute to the regulation of cartilage metabolism and bone remodeling. We have shown previously that induction of heme oxygenase-1 (HO-1) protects OA cartilage against inflammatory and degradative responses. In this study, we investigated the effects of HO-1 induction on OA osteoblast metabolism. HO-1 was induced with cobalt protoporphyrin IX (CoPP) and by transduction with LV-HO-1. In osteoblasts stimulated with interleukin (IL)-1β, CoPP enhanced mineralization, the expression of a number of markers of osteoblast differentiation such as Runx2, bone morphogenetic protein-2, osteocalci…

Malemedicine.medical_specialtyInterleukin-1betaCartilage metabolismBiochemistryBone remodelingOsteoprotegerinInternal medicineOsteoarthritismedicineHumansCells CulturedCellular SenescenceOsteitisAgedPharmacologyOsteoblastsbiologyChemistryInterleukinOsteoblastMiddle AgedCOPPHeme oxygenaseMetabolismmedicine.anatomical_structureEndocrinologyOsteocalcinbiology.proteinFemaleInflammation MediatorsHeme Oxygenase-1Biochemical Pharmacology
researchProduct

Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advance…

2017

We determined whether serum levels of Receptor Activator for Nuclear Factor κ B Ligand (RANKL), Osteoprotegerin (OPG), and the RANKL/OPG ratio could be useful biomarkers for the severity of oral lesions in bisphosphonate-related osteonecrosis of the jaw (BRONJ). A case-control study in which Group 1 consisted of 41 patients with BRONJ due to bisphosphonates, and Group 2 consisted of 44 healthy control cases. The plasma levels of RANKL and OPG were analyzed by an ELISA assay. The OPG/RANKL ratio was also calculated. We determined if the mean serum values differed among the different stages of BRONJ. Serum levels of RANKL were lower in Group 1 than in Group 2 (p =0.01), and serum levels of OP…

Malemusculoskeletal diseases0301 basic medicinemedicine.medical_specialtyNecrosismedicine.medical_treatmentOdontologíaSeverity of Illness IndexNecrosis03 medical and health sciences0302 clinical medicineOsteoprotegerinInternal medicinemedicineHumansReceptorGeneral DentistryUNESCO:CIENCIAS MÉDICASAgedOral Medicine and PathologyBisphosphonate-associated osteonecrosis of the jawbiologybusiness.industryResearchRANK LigandOsteoprotegerinCase-control studyBisphosphonatemedicine.disease030104 developmental biologyEndocrinologyOtorhinolaryngologyRANKLCase-Control Studies030220 oncology & carcinogenesisDisease Progressionbiology.proteinBisphosphonate-Associated Osteonecrosis of the JawFemaleSurgerymedicine.symptomOsteonecrosis of the jawbusinessBiomarkersMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Autophagy Induces Expression of IL-6 in Human Periodontal Ligament Fibroblasts Under Mechanical Load and Overload and Effects Osteoclastogenesis in v…

2021

Frontiers in physiology 12, 716441 (2021). doi:10.3389/fphys.2021.716441 special issue: "Alveolar Bone: a Pivotal Role in Periodontal Disease Pathobiology and Treatment, Volume I / Fani Anagnostou, Beatriz Castaneda, Frédéric Lézot and Petros Papagerakis"

Mechanical overloadautophagymechanical loadPhysiologymedicine.medical_treatmentADAM10Matrix metalloproteinaseOsteoprotegerinhuman periodontal ligament fibroblastsPhysiology (medical)medicineQP1-981cell-cell communicationOriginal ResearchIL-6ADAM17biologyChemistryAutophagyADAM10OsteoblastCell biologymechanical overloadCytokinemedicine.anatomical_structureRANKLbiology.proteinFrontiers in Physiology
researchProduct

Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study

2013

Objectives: Traditional clinical risk factors are associated with inflammation cross-sectionally, but associations of longitudinal variation in inflammatory biomarkers with corresponding changes in clinical risk factors are incompletely described. We sought to analyze clinical factors associated with change in inflammation in the community.Methods: We studied 3013 Framingham Offspring (n = 2735) and Omni Cohort (n = 278) participants (mean age 59 years, 55% women, 9% ethnic/racial minority) who attended two consecutive examination cycles (mean 6.7 years apart). We selected ten inflammatory biomarkers representing distinctive biological functions: C-reactive protein (CRP), intercellular adhe…

OncologyMaleBLOOD-PRESSUREIsoprostanesFramingham Heart StudyRisk FactorsMyocardial infarctionOXIDATIVE STRESSskin and connective tissue diseasesChemokine CCL2Biological markersbiologyLongitudinal studiesMiddle AgedIntercellular Adhesion Molecule-1Inflammatory biomarkersC-REACTIVE PROTEINP-SelectinADIPOSE-TISSUEMassachusettsCardiovascular DiseasesCARDIOVASCULAR-DISEASEFemalemedicine.symptomCardiology and Cardiovascular MedicineVasculitisVasculitismedicine.medical_specialtyInflammationArticleInternal medicinemedicineHumansReceptors Tumor Necrosis Factor Type IIInterleukin 6AgedInflammationbusiness.industryInterleukin-6PERIPHERAL ARTERIAL-DISEASEC-reactive proteinOsteoprotegerinADHESION MOLECULE-1medicine.diseasePHOSPHOLIPASE A(2)Blood pressurePLASMA-CONCENTRATIONMYOCARDIAL-INFARCTIONImmunology1-Alkyl-2-acetylglycerophosphocholine Esterasebiology.proteinsense organsbusinessBiomarkers
researchProduct

Conjunctival Sac Fluid Contains Elevated Levels of Soluble TRAIL: Implications for the Anti-Tumoral Surveillance of the Anterior Surface of the Eye

2008

Little is known on the ability of different epithelia to release soluble TNF-related apoptosis-inducing ligand (TRAIL) and the relevance of TRAIL secretion by epithelial cells is still incompletely understood. On these bases, we have measured the concentration of soluble TRAIL by ELISA in the conjunctival sac fluid. It was the highest ever detected in a biological fluid (mean value of 26,800 pg/ml), being approximately 20-fold greater than that found in human saliva and >200-fold greater than that detected in human serum. On the other hand, osteoprotegerin, the soluble decoy receptor of TRAIL, was almost undetectable in the conjunctival sac fluid. Of note, the levels of soluble TRAIL measur…

SalivaConjunctivaPhysiologyConjunctival sac fluidClinical BiochemistryApoptosisTRAILIn Vitro TechniquesBiologySettore MED/42 - Igiene Generale E ApplicataPhotorefractive Keratectomycorneal ephiteliumFlow cytometryCorneaTNF-Related Apoptosis-Inducing LigandOsteoprotegerinCell Line TumorCorneamedicineHumansCorneal epitheliumcorneal epitheliummedicine.diagnostic_testEye NeoplasmsOsteoprotegerinEpithelial CellsCell BiologyMolecular biologyRecombinant ProteinsBody Fluidsmedicine.anatomical_structureSolubilityanti-tumoral surveillanceImmunologyConjunctival sacImmunohistochemistrytrail; conjunctival sac fluid; corneal ephitelium; anti-tumoral surveillance.Conjunctiva
researchProduct